CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes.
The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
理解肿瘤微环境(TME)中不同贡献者的功能和交流方式对于有效的癌症检测和治疗至关重要。TME涵盖肿瘤的所有周围环境,如血管、成纤维细胞、免疫细胞、信号分子、外泌体和细胞外基质(ECM)。
因此,有效的癌症治疗依赖于解决TME的改变,这些改变是肿瘤进展、免疫逃逸和转移的已知驱动因素。免疫细胞和其他细胞类型在癌性条件下表现不同,或驱动或阻碍癌症进展。例如,TIL(肿瘤浸润淋巴细胞)(TILs)包括B细胞和T细胞类型的淋巴细胞,它们能够侵入恶性肿瘤,引入并增强免疫系统识别和摧毁癌细胞的能力。
因此,TILs展示了一种应对TME改变的有前景的方法,并具有显著阻碍癌症进展的能力。同样,外泌体和炎症小体表现出双重效应,根据外泌体的来源、炎症小体的类型和肿瘤的不同,导致肿瘤进展或抑制。本综述将探讨细胞在肿瘤存在下的功能、癌细胞与免疫细胞之间的交流,以及TILs、外泌体和炎症小体在TME中的作用。本综述的工作旨在引起对更安全、更持久的癌症疗法的兴趣,同时为推进癌症治疗并 consequently 提高生存率提供一条有前景的途径。
Understanding how different contributors within the tumor microenvironment (TME) function and communicate is essential for effective cancer detection and treatment. The TME encompasses all the surroundings of a tumor such as blood vessels, fibroblasts, immune cells, signaling molecules, exosomes, and the extracellular matrix (ECM). Subsequently, effective cancer therapy relies on addressing TME alterations, known drivers of tumor progression, immune evasion, and metastasis.
Immune cells and other cell types act differently under cancerous conditions, either driving or hindering cancer progression. For instance, tumor-infiltrating lymphocytes (TILs) include lymphocytes of B and T cell types that can invade malignancies, bringing in and enhancing the ability of immune system to recognize and destroy cancer cells.
Therefore, TILs display a promising approach to tackling the TME alterations and have the capability to significantly hinder cancer progression. Similarly, exosomes and inflammasomes exhibit a dual effect, resulting in either tumor progression or inhibition depending on the origin of exosomes, type of inflammasome and tumor.
This review will explore how cells function in the presence of a tumor, the communication between cancer cells and immune cells, and the role of TILs, exosomes and inflammasomes within the TME. The efforts in this review are aimed at garnering interest in safer and durable therapies for cancer, in addition to providing a promising avenue for advancing cancer therapy and consequently improving survival rates.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。